IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden · Delayed Price · Currency is SEK 1.690
+0.058 (3.55%)
At close: Feb 10, 2026
IRLAB Therapeutics AB Market Cap
IRLAB Therapeutics AB has a market cap or net worth of 143.55 million as of February 11, 2026. Its market cap has decreased by -82.37% in one year.
Market Cap
143.55M
Enterprise Value
63.22M
Revenue
85.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.69
Market Cap Chart
Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 143.55M, a decrease of -65.24%. That is a compound annual growth rate of -11.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 143.55M | -14.21% |
| Dec 30, 2025 | 167.33M | -69.99% |
| Dec 30, 2024 | 557.59M | 43.33% |
| Dec 29, 2023 | 389.01M | -80.42% |
| Dec 30, 2022 | 1.99B | -12.75% |
| Dec 30, 2021 | 2.28B | 4.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 218.38M |
| Initiator Pharma | 205.36M |
| Sprint Bioscience AB | 197.31M |
| Isofol Medical AB | 168.52M |
| NextCell Pharma AB | 167.09M |
| Simris Group AB (PUBL) | 167.02M |
| Biovica International AB | 128.15M |
| Alligator Bioscience AB | 112.25M |